Abstract

BackgroundThe stabilizing and function-preserving effects of ectoines have attracted considerable biotechnological interest up to industrial scale processes for their production. These rely on the release of ectoines from high-salinity-cultivated microbial producer cells upon an osmotic down-shock in rather complex processor configurations. There is growing interest in uncoupling the production of ectoines from the typical conditions required for their synthesis, and instead design strains that naturally release ectoines into the medium without the need for osmotic changes, since the use of high-salinity media in the fermentation process imposes notable constraints on the costs, design, and durability of fermenter systems.ResultsHere, we used a Corynebacterium glutamicum strain as a cellular chassis to establish a microbial cell factory for the biotechnological production of ectoines. The implementation of a mutant aspartokinase enzyme ensured efficient supply of L-aspartate-beta-semialdehyde, the precursor for ectoine biosynthesis. We further engineered the genome of the basic C. glutamicum strain by integrating a codon-optimized synthetic ectABCD gene cluster under expressional control of the strong and constitutive C. glutamicum tuf promoter. The resulting recombinant strain produced ectoine and excreted it into the medium; however, lysine was still found as a by-product. Subsequent inactivation of the L-lysine exporter prevented the undesired excretion of lysine while ectoine was still exported. Using the streamlined cell factory, a fed-batch process was established that allowed the production of ectoine with an overall productivity of 6.7 g L-1 day-1 under growth conditions that did not rely on the use of high-salinity media.ConclusionsThe present study describes the construction of a stable microbial cell factory for recombinant production of ectoine. We successfully applied metabolic engineering strategies to optimize its synthetic production in the industrial workhorse C. glutamicum and thereby paved the way for further improvements in ectoine yield and biotechnological process optimization.

Highlights

  • The stabilizing and function-preserving effects of ectoines have attracted considerable biotechnological interest up to industrial scale processes for their production

  • Design of the cellular chassis for ectoine synthesis For heterologous synthesis of ectoine in C. glutamicum, a basic lysine-producer was chosen as a suitable genetic background

  • This strain, C. glutamicum LYS-1, possesses a feedback-resistant aspartokinase (LysC-T311I) [53] and thereby circumvents the native biochemical pathway regulation for the synthesis of ASA that normally keeps the cellular pool of this central metabolite under tight

Read more

Summary

Introduction

The stabilizing and function-preserving effects of ectoines have attracted considerable biotechnological interest up to industrial scale processes for their production. Ectoines possess excellent stabilizing effects on biological molecules; e.g. proteins, cell membranes, DNA, and even entire cells They safeguard proteins against aggregation, promote their proper folding under otherwise denaturing conditions, and they are fully compliant with cellular physiology, biochemistry and protein functions [9,10,11,12]. Related to these attractive properties, industry has merchandized ectoines as protective compounds for health care products and cosmetics [7,13,14]. Some natural producers can avert this through the co-production of an aspartokinase (Ask_Ect) with special biochemical features [33]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call